dantrolene sodium
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
21 FDA-registered drug labelers
American Health Packaging
Amneal Pharmaceuticals of New York LLC
AvPAK
Azico Biophore India Private Limited
Bryant Ranch Prepack
Cardinal Health 107, LLC
Catalent Micron Technologies, Inc.
Darmerica, LLC
Eagle Pharmaceuticals, Inc.
Elite Laboratories, Inc.
Endo USA, Inc.
HAS Healthcare Advanced Synthesis SA
Hikma Pharmaceuticals USA Inc.
Isomedix Operations Inc
MAEDA INC
Major Pharmaceuticals
Par Health USA, LLC
ProPharma Distribution
ScinoPharm Taiwan Ltd.
Spectrum Laboratory Products, Inc.
USWM, LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 5 drug and cosmetic product listings (FDA).
- •Dantrolene
- •Dantrolene Sodium
- •Revonto
- •Dantrium
- •Ryanodex dantrolene sodium
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS14663-23-1
PubChem CID6604100
DTXSIDDTXSID4044585
FormulaC14H9N4NaO5
Mol. Weight336.23 g/mol
SMILESC1C(=NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])[O-].[Na+]
Data Sources
66041002026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/dantrolene sodium/cids/JSON
Archive: data/sources/pubchem_name/dantrolene sodium.json
CAS 14663-23-12026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json